Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Napierala, Marek  [Clear All Filters]
2015
Butler JSergeskett, Napierala M. Friedreich's ataxia - a case of aberrant transcription termination?. Transcription. 2015.
2016
Bhalla AD, Khodadadi-Jamayran A, Li Y, Lynch DR, Napierala M. Deep sequencing of mitochondrial genomes reveals increased mutation load in Friedreich's ataxia. Ann Clin Transl Neurol. 2016;3(7):523-536.
Butler JSergeskett, Napierala M. New Reasons to Pursue the Therapeutic Potential of Synthetic Nucleic Acids for Neurological Diseases. JAMA Neurol. 2016.
2018
Libby CJ, Zhang S, Benavides GA, Scott SE, Li Y, Redmann M, Tran ANhat, Otamias A, Darley-Usmar V, Napierala M, et al. Identification of Compounds That Decrease Glioblastoma Growth and Glucose Uptake in Vitro. ACS Chem Biol. 2018.
2019
Li J, Rozwadowska N, Clark A, Fil D, Napierala JS, Napierala M. Excision of the expanded GAA repeats corrects cardiomyopathy phenotypes of iPSC-derived Friedreich's ataxia cardiomyocytes. Stem Cell Res. 2019;40:101529.
2021
Williford SE, Libby CJ, Ayokanmbi A, Otamias A, Gordillo JJ, Gordon ER, Cooper SJ, Redmann M, Li Y, Griguer C, et al. Novel dopamine receptor 3 antagonists inhibit the growth of primary and temozolomide resistant glioblastoma cells. PLoS One. 2021;16(5):e0250649.
Li Y, Li J, Wang J, Lynch DR, Shen X, Corey DR, Parekh D, Bhat B, Woo C, Cherry JJ, et al. Targeting 3' and 5' untranslated regions with antisense oligonucleotides to stabilize frataxin mRNA and increase protein expression. Nucleic Acids Res. 2021.
2022
Wang D, Ho ES, M Cotticelli G, Xu P, Napierala JS, Hauser LA, Napierala M, Himes BE, Wilson RB, Lynch DR, et al. Skin fibroblast metabolomic profiling reveals that lipid dysfunction predicts the severity of Friedreich's ataxia. J Lipid Res. 2022:100255.